ArticleJournal of oncology2020

Circulating Tumor DNA Using Tagged Targeted Deep Sequencing to Assess Minimal Residual Disease in Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy.

Gabriella Cirmena et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.